Article
Rap2c as a Novel Biomarker for Predicting Poor Prognosis in Glioma
OncoTargets and Therapy · 2020 · Wang X, Wang C, Xi L, Yu Z
Key facts
| Title | Rap2c as a Novel Biomarker for Predicting Poor Prognosis in Glioma |
|---|---|
| First author | Wang X, Wang C, Xi L, Yu Z |
| Journal | OncoTargets and Therapy |
| Published | Apr 14, 2020 |
| DOI | 10.2147/OTT.S247731 |
| Devices mentioned | 071714, 215006 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1